Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholangiocarcinoma: a review

P J Thuluvath1, R Rai, A C Venbrux

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

The Gastroenterologist
|January 22, 1998
PubMed
Summary

Cholangiocarcinoma, a bile duct cancer, is diagnosed using imaging and tumor markers like CA 19-9. Surgical resection offers the best cure chance, with survival rates varying by tumor location.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overuse of subtotal cholecystectomy: surgeon practice patterns and outcomes in a large healthcare system.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2026
Same author

Early Intervention in Post-operative Infectious Spondylodiscitis: Outcome of Aggressive Transforaminal Lumbar Interbody Fusion.

Malaysian orthopaedic journal·2024
Same author

HLA-E and NKG2A Mediate Resistance to BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer.

bioRxiv : the preprint server for biology·2024
Same author

MEDITERRANEAN DIET AND ITS IMPACT ON THE ILLNESS CHARACTERISTIC OF YOUTH WITH IRRITABLE BOWEL CONDITION.

Georgian medical news·2024
Same author

Dynamic Contrast-enhanced Magnetic Resonance Imaging Evaluation of Whole Tumour Perfusion Heterogeneity Predicts Distant Disease-free Survival in Locally Advanced Rectal Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

Comment on: Multimodal analgesia with thoracic epidural after transthoracic oesophagectomy: Do we need more evidence?

The British journal of surgery·2021

Area of Science:

  • Gastroenterology and Hepatology
  • Surgical Oncology

Background:

  • Cholangiocarcinoma (bile duct cancer) has multiple risk factors, including bile duct dilation and infections.
  • Jaundice is a common presenting symptom, and diagnosis often begins with imaging like ultrasound or CT scans.
  • Elevated tumor markers, such as carcinoembryonic antigen (CEA) or CA 19-9, can suggest the diagnosis.

Purpose of the Study:

  • To outline the diagnostic modalities for cholangiocarcinoma.
  • To describe the factors influencing management decisions.
  • To present the prognostic outcomes based on surgical resection and tumor location.

Main Methods:

  • Diagnosis is aided by imaging (ultrasound, CT, MRI), tumor markers (CEA, CA 19-9), cholangiography, and tissue confirmation via cytology or biopsy.
  • Treatment planning involves a multidisciplinary approach considering patient factors, tumor location, and resectability.
  • Surgical resection is the primary curative treatment, with resectability assessed using advanced imaging and angiography.

Main Results:

  • Tissue diagnosis is achieved in 60-70% of patients through various cytologic methods.
  • Five-year survival rates after curative resection for hilar cholangiocarcinoma are 0-22% (mean 14%), and for distal cholangiocarcinoma, 0-39% (mean 25%).
  • Palliative decompression is an option for unresectable cases.

Conclusions:

  • Early suspicion and diagnosis of cholangiocarcinoma are crucial.
  • Complete surgical resection remains the only curative option.
  • Prognosis is significantly influenced by tumor location and successful resection.

Related Experiment Videos